Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
- PMID: 2501811
- DOI: 10.1007/BF00451682
Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
Abstract
Behavioral profiles composed of both locomotor activity and investigatory behavior were established for the 5HT-1A agonists 8OHDPAT, buspirone, gepirone, and ipsapirone using rats tested in a Behavioral Pattern Monitor. Typically these compounds dose-relatedly decreased horizontal locomotion and investigatory activity during the first half of the 1-h test session. Time-course studies revealed that the time interval between injection and placement of the animal in the testing chamber made no difference in the temporal distribution of locomotor activity following most 5HT-1A agonists. These results were compared and contrasted to the behavioral profiles previously established for hallucinogenic compounds such as LSD and DOM, the psychoactive properties of which have been suggested to be mediated by 5HT-2 binding sites. Examination of ipsapirone and 8OHDPAT in a familiar environment paradigm revealed that both drugs decreased behavioral responding independently of the animals' familiarity with the test environment, in contrast to the behaviorally suppressive effects of hallucinogenic 5HT-2 antagonists which disappear in a familiar environment. Additionally, d,l-propranolol was used as a 5HT-1 antagonist and was found to block the behavioral effects of the 5HT-1A agonists ipsapirone and buspirone without having significant effects by itself. Propranolol was also used to identify the contribution of the 5HT-1 binding site to the behavioral effects of LSD. Even at relatively high doses, propranolol only partially antagonized the effects of LSD, supporting the hypothesis that the behavioral effects of LSD reflect the activation of both 5HT-1 and 5HT-2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
5HT-2 mediation of acute behavioral effects of hallucinogens in rats.Psychopharmacology (Berl). 1990;100(3):417-25. doi: 10.1007/BF02244617. Psychopharmacology (Berl). 1990. PMID: 2138338
-
Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.Psychopharmacology (Berl). 1991;105(1):69-76. doi: 10.1007/BF02316866. Psychopharmacology (Berl). 1991. PMID: 1745714
-
Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.Neuropsychopharmacology. 1998 May;18(5):339-51. doi: 10.1016/S0893-133X(97)00164-4. Neuropsychopharmacology. 1998. PMID: 9536447
-
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. doi: 10.1016/j.ejphar.2005.09.065. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16310183 Review.
-
Serotonergic functions in arousal and motor activity.Behav Brain Res. 1996;73(1-2):31-5. doi: 10.1016/0166-4328(96)00065-4. Behav Brain Res. 1996. PMID: 8788473 Review.
Cited by
-
Functional behavioral homology between rat 5-HT1B and guinea pig 5-HT1D receptors in the modulation of prepulse inhibition of startle.Psychopharmacology (Berl). 1996 Jun;125(3):231-7. doi: 10.1007/BF02247333. Psychopharmacology (Berl). 1996. PMID: 8815958
-
Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.Psychopharmacology (Berl). 1994 Jan;113(3-4):429-37. doi: 10.1007/BF02245219. Psychopharmacology (Berl). 1994. PMID: 7862855
-
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.Psychopharmacology (Berl). 2003 Aug;168(4):397-409. doi: 10.1007/s00213-003-1389-y. Epub 2003 Apr 30. Psychopharmacology (Berl). 2003. PMID: 12721776
-
The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig.Br J Pharmacol. 1994 Jul;112(3):861-6. doi: 10.1111/j.1476-5381.1994.tb13159.x. Br J Pharmacol. 1994. PMID: 7921613 Free PMC article.
-
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.CNS Drugs. 2023 Sep;37(9):733-754. doi: 10.1007/s40263-023-01008-5. Epub 2023 Aug 21. CNS Drugs. 2023. PMID: 37603260 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources